Pain and allodynia/hyperalgesia induced by intramuscular injection of serotonin in patients with fibromyalgia and healthy individuals

Pain

Volumn 85, Issue 1-2, 2000, Pages 31-39

  Ernberg, Malin ^a   Lundeberg, Thomas ^a   Kopp, Sigvard ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

5 Hydroxytryptamine; Double blind method; Fibromyalgia; Pain threshold; Visual analogue pain scale

Indexed keywords

BUSPIRONE; CHLORZOXAZONE; CITALOPRAM; PARACETAMOL; SALICYLIC ACID; SEROTONIN; SERTRALINE; TRAMADOL;

ADULT; ALLODYNIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; FIBROMYALGIA; HUMAN; HUMAN CELL; HUMAN TISSUE; MASSETER MUSCLE; PAIN THRESHOLD; PRIORITY JOURNAL; SEROTONIN RELEASE;

ADULT; DOUBLE-BLIND METHOD; FEMALE; FIBROMYALGIA; HUMANS; HYPERALGESIA; INJECTIONS, INTRAMUSCULAR; MASSETER MUSCLE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PRESSURE; SEROTONIN;

EID: 0033983944     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(99)00233-X     Document Type: Article

References (25)

1. Babenko V., Graven-Nielsen T., Svensson P., Drewes A.M., Jensen T.S., Arendt-Nielsen L. Experimental human muscle pain and muscular hyperalgesia induced by combinations of serotonin and bradykinin. Pain. 82:1999;1-8.
2. Bennett R.M. Fibromyalgia and the disability dilemma: a new era in understanding a complex, multidimensional pain syndrome. Arthritis Rheum. 39:1996;1627-1634.
3. Candito M., Souetre E., Iordache A., Pringuey D., Ardisson J.L., Chambon P., Darcourt G. Diurnal variation in total plasma tryptophan in controls and in depression. J Psychiatr Res. 24:1990;227-230.
4. Eide P.K., Hole K. The role of 5-hydroxytryptamine (5-HT) receptor subtypes and plasticity in the 5-HT systems in the regulation of nociceptive sensitivity. Cephalalgia. 13:1993;75-85.
5. Eriksson P.O., Lindman R., Stål P., Bengtsson A. Symptoms and signs of mandibular dysfunction in primary fibromyalgia syndrome (PSF) patients. Swed Dent J. 12:1988;141-149.
6. Ernberg M., Hedenberg-Magnusson B., Alstergren P., Kopp S. The level of serotonin in the superficial masseter muscle in relation to local pain and allodynia. Life Sci. 65:1999;313-325.
7. Hedenberg-Magnusson B., Ernberg M., Kopp S. Symptoms and signs of temporomandibular disorders in patients with fibromyalgia and local myalgia of the temporomandibular system: a comparative study. Acta Odontol Scand. 6:1997;344-349.
8. Henriksson K.G., Bengtsson A. Fibromyalgia-a clinical entity? Can J Physiol Pharmacol. 69:1991;672-677.
9. Hrycaj P., Stratz T., Mennet P., Muller W. Pathogenetic aspects of responsiveness to ondansetron (5-hydroxytryptamine type 3 receptor antagonist) in patients with primary fibromyalgia syndrome - a preliminary study. J Rheumatol. 23:1996;1418-1423.
10. Jensen K., Tuxen C., Pedersen-Bjergaard U., Jansen I., Edvinsson L., Olesen J. Pain and tenderness in human temporal muscle induced by bradykinin and 5-hydroxytryptamine. Peptides. 11:1990;1127-1132.
11. Kosek E., Ekholm J., Hansson P. Sensory dysfunction in fibromyalgia patients with implications for pathogenic mechanisms. Pain. 68:1996;375-383.
12. Mense S. Nociception from skeletal muscle in relation to clinical muscle pain. Pain. 54:1993;241-289.
13. Mense S., Meyer H. Bradykinin-induced modulation of the response behaviour of different types of feline group III and IV muscle receptors. J Physiol (Lond). 398:1988;49-63.
14. Russell I.J. A metabolic basis for fibromyalgia syndrome. Vaeroy H., Merskey H. Progress in fibromyalgia and myofacial pain. 1993;283-309 Elsevier Science Publishers, Amsterdam.
15. Russell I.J. Advances in fibromyalgia: possible role for central neurochemicals. Am J Med Sci. 315:1998;377-384.
16. Russell I.J. Neurochemical pathogenesis of fibromyalgia. Z Rheumatol, 57 Suppl 2:1998;63-66.
17. Scudds R.A., Rollman G.B., Harth M., McCain G.A. Pain perception and personality measures as discriminators in the classification of fibrositis. J Rheumatol. 14:1987;563-569.
18. Stratz T., Samborski W., Hrycaj P., Pap T., Mackiewicz S., Mennet P., Muller W. Die serotoninkonzentration im serum bei patienten mit generalisierter tendomyopathie (fibromyalgie) und chronischer polyarthritis. Med Klin. 88:1993;458-462.
19. Sörensen J., Graven-Nielsen T., Henriksson K.G., Bengtsson M., Arendt-Nielsen L. Hyperexcitability in fibromyalgia. J Rheumatol. 25:1998;152-155.
20. Taiwo Y.O., Levine J.D. Serotonin is a directly-acting hyperalgesic agent in the rat. Neuroscience. 48:1992;485-490.
21. Travell J. Temporomandibular joint pain referred from muscles of the head and neck. J Prosthet Dent. (10):1960;745-763.
22. Wolfe F., Smythe H.A., Yunus M.B., Bennett R.M., Bombardier C., Goldenberg D.L., Tugwell P., Campbell S.M., Abeles M., Clark P., Fam A.G., Farber S.J., Fiechtner J.J., Franklin C.M., Gatter R.A., Hamaty D., Lessard J., Lichtbroun A.S., Masi A.T., McCain G.A., Reynolds W.J., Romano T.J., Russell I.J., Sheon R.P. The American College of Rheumatology 1990. Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria. Arthritis Rheum. 33:1990;160-172.
23. Wolfe F., Russell I.J., Vipraio G., Ross K., Anderson J. Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. J Rheumatol. 24:1997;555-559.
24. Wolfe F., Anderson J., Harkness D., Bennett R.M., Caro X.J., Goldenberg D.L., Russell I.J., Yunus M.B. Work and disability status of persons with fibromyalgia. J Rheumatol. 24:1997;1171-1178.
25. Yunus M.B. Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanisms with peripheral modulation. J Rheumatol. 19:1992;846-850.